100
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Effect of preventive treatment with botulinum toxin type A on acute headache medication usage in migraine patients

Pages 49-53 | Published online: 22 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ira M Turner, Stephen M Newman, Erik J Entin & Tiffany Agrillo. (2007) Prophylactic treatment of migraine with botulinum toxin type A: a pharmacoeconomic analysis in a community setting. Journal of Medical Economics 10:4, pages 355-366.
Read now

Articles from other publishers (4)

Ayushi S Dhengare & Darshna G Fulmali. (2022) The Development of Psychiatric Illness and Chemoprophylaxis of Botulinum Toxin in Migraine: A Narrative Review. Cureus.
Crossref
Wanying Chen, Xiaoyu Zhang, Yingying Xu, Zemin Xu, Haiyan Qin & Lianbo Zhang. (2021) Ultrasound-guided five-point injection of botulinum toxin for patients with trapezius hypertrophy. Journal of Orthopaedic Surgery and Research 16:1.
Crossref
Valerie W. Chan, E. Jane McCabe & Daune L. MacGregor. (2009) Botox Treatment for Migraine and Chronic Daily Headache in Adolescents. Journal of Neuroscience Nursing 41:5, pages 235-243.
Crossref
Andrew Blumenfeld. (2004) Botulinum Toxin Type A for the Treatment of Headache: Pro. Headache: The Journal of Head and Face Pain 44:8, pages 825-830.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.